skip to content
Biomaterials and Bioactive Molecules to Drive Differentiation in Striated Muscle Tissue Engineering Preview this item
ClosePreview this item
Checking...

Biomaterials and Bioactive Molecules to Drive Differentiation in Striated Muscle Tissue Engineering

Author: Dario Coletti; Giancarlo Forte; Valentina Di Felice
Publisher: [s.l.] Frontiers Media SA 2016
Edition/Format:   eBook : Document
Summary:
Tissue engineering is an innovative, multidisciplinary approach which combines (bio)materials, cells and growth factors with the aim to obtain neo-organogenesis to repair or replenish damaged tissues and organs. The generation of engineered tissues and organs (e. g. skin and bladder) has entered into the clinical practice in response to the chronic lack of organ donors. In particular, for the skeletal and cardiac  Read more...
Rating:

(not yet rated) 0 with reviews - Be the first.

Subjects
More like this

Find a copy online

Links to this item

Find a copy in the library

&AllPage.SpinnerRetrieving; Finding libraries that hold this item...

Details

Material Type: Document, Internet resource
Document Type: Book, Computer File, Internet Resource
All Authors / Contributors: Dario Coletti; Giancarlo Forte; Valentina Di Felice
ISBN: 9782889198412 2889198413
OCLC Number: 1004185682
Language Note: English
Description: 1 Online-Ressource (1 electronic resource (90 p.))

Abstract:

Tissue engineering is an innovative, multidisciplinary approach which combines (bio)materials, cells and growth factors with the aim to obtain neo-organogenesis to repair or replenish damaged tissues and organs. The generation of engineered tissues and organs (e. g. skin and bladder) has entered into the clinical practice in response to the chronic lack of organ donors. In particular, for the skeletal and cardiac muscles the translational potential of tissue engineering approaches has clearly been shown, even though the construction of this tissue lags behind others given the hierarchical, highly organized architecture of striated muscles. Cardiovascular disease is the leading cause of death in the developed world, where the yearly incidence of Acute MI (AMI) is approx 2 million cases in Europe. Recovery from AMI and reperfusion is still less than ideal. Stem cell therapy may represent a valid treatment. However, delivery of stem cells alone to infarcted myocardium provides no structural support while the myocardium heals, and the injected stem cells do not properly integrate into the myocardium because they are not subjected to the mechanical forces that are known to drive myocardial cellular physiology. On the other hand, there are many clinical cases where the loss of skeletal muscle due to a traumatic injury, an aggressive tumour or prolonged denervation may be cured by the regeneration of this tissue. In vivo, stem or progenitor cells are sheltered in a specialized microenvironment (niche), which regulates their survival, proliferation and differentiation. The goal of this research topic is to highlight the available knowledge on biomaterials and bioactive molecules or a combination of them, which can be used successfully to differentiate stem or progenitor cells into beating cardiomyocytes or organized skeletal muscle in vivo. Innovations compared to the on-going trials may be: 1) the successful delivery of stem cells using sutural scaffolds instead of intracoronary or intramuscular injections; 2) protocols to use a limited number of autologous or allogeneic stem cells; 3) methods to drive their differentiation by modifying the chemical-physical properties of scaffolds or biomaterials, incorporating small molecules (i.e. miRNA) or growth factors; 4) methods to tailor the scaffolds to the elastic properties of the muscle; 5) studies which suggest how to realize scaffolds that optimize tissue functional integration, through the combination of the most ...

Reviews

User-contributed reviews
Retrieving GoodReads reviews...
Retrieving DOGObooks reviews...

Tags

Be the first.

Similar Items

Confirm this request

You may have already requested this item. Please select Ok if you would like to proceed with this request anyway.

Linked Data


Primary Entity

<http://www.worldcat.org/oclc/1004185682> # Biomaterials and Bioactive Molecules to Drive Differentiation in Striated Muscle Tissue Engineering
    a schema:CreativeWork, schema:MediaObject, schema:Book ;
    library:oclcnum "1004185682" ;
    schema:about <http://experiment.worldcat.org/entity/work/data/4498087742#Topic/physiology> ; # Physiology
    schema:about <http://experiment.worldcat.org/entity/work/data/4498087742#Topic/science_general> ; # Science (General)
    schema:author <http://experiment.worldcat.org/entity/work/data/4498087742#Person/coletti_dario> ; # Dario Coletti
    schema:author <http://experiment.worldcat.org/entity/work/data/4498087742#Person/felice_valentina_di> ; # Valentina Di Felice
    schema:author <http://experiment.worldcat.org/entity/work/data/4498087742#Person/forte_giancarlo> ; # Giancarlo Forte
    schema:bookFormat schema:EBook ;
    schema:datePublished "2016" ;
    schema:description "Tissue engineering is an innovative, multidisciplinary approach which combines (bio)materials, cells and growth factors with the aim to obtain neo-organogenesis to repair or replenish damaged tissues and organs. The generation of engineered tissues and organs (e. g. skin and bladder) has entered into the clinical practice in response to the chronic lack of organ donors. In particular, for the skeletal and cardiac muscles the translational potential of tissue engineering approaches has clearly been shown, even though the construction of this tissue lags behind others given the hierarchical, highly organized architecture of striated muscles. Cardiovascular disease is the leading cause of death in the developed world, where the yearly incidence of Acute MI (AMI) is approx 2 million cases in Europe. Recovery from AMI and reperfusion is still less than ideal. Stem cell therapy may represent a valid treatment. However, delivery of stem cells alone to infarcted myocardium provides no structural support while the myocardium heals, and the injected stem cells do not properly integrate into the myocardium because they are not subjected to the mechanical forces that are known to drive myocardial cellular physiology. On the other hand, there are many clinical cases where the loss of skeletal muscle due to a traumatic injury, an aggressive tumour or prolonged denervation may be cured by the regeneration of this tissue. In vivo, stem or progenitor cells are sheltered in a specialized microenvironment (niche), which regulates their survival, proliferation and differentiation. The goal of this research topic is to highlight the available knowledge on biomaterials and bioactive molecules or a combination of them, which can be used successfully to differentiate stem or progenitor cells into beating cardiomyocytes or organized skeletal muscle in vivo. Innovations compared to the on-going trials may be: 1) the successful delivery of stem cells using sutural scaffolds instead of intracoronary or intramuscular injections; 2) protocols to use a limited number of autologous or allogeneic stem cells; 3) methods to drive their differentiation by modifying the chemical-physical properties of scaffolds or biomaterials, incorporating small molecules (i.e. miRNA) or growth factors; 4) methods to tailor the scaffolds to the elastic properties of the muscle; 5) studies which suggest how to realize scaffolds that optimize tissue functional integration, through the combination of the most ..." ;
    schema:exampleOfWork <http://worldcat.org/entity/work/id/4498087742> ;
    schema:name "Biomaterials and Bioactive Molecules to Drive Differentiation in Striated Muscle Tissue Engineering" ;
    schema:productID "1004185682" ;
    schema:url <http://journal.frontiersin.org/researchtopic/1967/biomaterials-and-bioactive-molecules-to-drive-differentiation-in-striated-muscle-tissue-engineering> ;
    schema:url <https://www.doabooks.org/doab?func=fulltext&rid=18228> ;
    schema:url <http://www.doabooks.org/doab?func=fulltext&rid=18228> ;
    schema:workExample <http://worldcat.org/isbn/9782889198412> ;
    wdrs:describedby <http://www.worldcat.org/title/-/oclc/1004185682> ;
    .


Related Entities

<http://experiment.worldcat.org/entity/work/data/4498087742#Person/coletti_dario> # Dario Coletti
    a schema:Person ;
    schema:familyName "Coletti" ;
    schema:givenName "Dario" ;
    schema:name "Dario Coletti" ;
    .

<http://experiment.worldcat.org/entity/work/data/4498087742#Person/felice_valentina_di> # Valentina Di Felice
    a schema:Person ;
    schema:familyName "Felice" ;
    schema:givenName "Valentina Di" ;
    schema:name "Valentina Di Felice" ;
    .

<http://experiment.worldcat.org/entity/work/data/4498087742#Person/forte_giancarlo> # Giancarlo Forte
    a schema:Person ;
    schema:familyName "Forte" ;
    schema:givenName "Giancarlo" ;
    schema:name "Giancarlo Forte" ;
    .

<http://experiment.worldcat.org/entity/work/data/4498087742#Topic/science_general> # Science (General)
    a schema:Intangible ;
    schema:name "Science (General)" ;
    .

<http://worldcat.org/isbn/9782889198412>
    a schema:ProductModel ;
    schema:isbn "2889198413" ;
    schema:isbn "9782889198412" ;
    .

<http://www.doabooks.org/doab?func=fulltext&rid=18228>
    rdfs:comment "Description of rights in Directory of Open Access Books (DOAB): Attribution (CC by)" ;
    .

<http://www.worldcat.org/title/-/oclc/1004185682>
    a genont:InformationResource, genont:ContentTypeGenericResource ;
    schema:about <http://www.worldcat.org/oclc/1004185682> ; # Biomaterials and Bioactive Molecules to Drive Differentiation in Striated Muscle Tissue Engineering
    schema:dateModified "2019-03-06" ;
    void:inDataset <http://purl.oclc.org/dataset/WorldCat> ;
    .

<https://www.doabooks.org/doab?func=fulltext&rid=18228>
    rdfs:comment "Description of rights in Directory of Open Access Books (DOAB): Attribution (CC by)" ;
    .


Content-negotiable representations

Close Window

Please sign in to WorldCat 

Don't have an account? You can easily create a free account.